middle.news

AdAlta Launches Groundbreaking CAR-T Collaboration, Raises $2.8M to Fuel Growth

8:46am on Friday 30th of January, 2026 AEDT Healthcare
Read Story

AdAlta Launches Groundbreaking CAR-T Collaboration, Raises $2.8M to Fuel Growth

8:46am on Friday 30th of January, 2026 AEDT
Key Points
  • Launch of 'East to West' cellular immunotherapy operations with Shanghai Cell Therapy Group
  • Co-development of BZDS1901, an armored CAR-T therapy for mesothelioma
  • $2.8 million raised through private placements, boosting cash reserves to $1.58 million
  • Full repayment of New Life Sciences Capital and Meurs Group investment agreements
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about ADALTA (ASX:1AD)
OPEN ARTICLE